UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000054820
Receipt number R000062640
Scientific Title Mydriatic Effects of Low Concentration Parasympatholytic Eye Drops in Normal Subjects
Date of disclosure of the study information 2024/06/29
Last modified on 2024/06/29 06:35:02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Mydriatic Effects of Low Concentration Parasympatholytic Eye Drops in Normal Subjects

Acronym

Mydriatic Effects of Low Concentration Parasympatholytic Eye Drops in Normal Subjects

Scientific Title

Mydriatic Effects of Low Concentration Parasympatholytic Eye Drops in Normal Subjects

Scientific Title:Acronym

Mydriatic Effects of Low Concentration Parasympatholytic Eye Drops in Normal Subjects

Region

Japan


Condition

Condition

Normal subjects

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effect of repeated ophthalmic administration of low concentrations of parasympatholytic agents on pupil diameter in adults.

Basic objectives2

Others

Basic objectives -Others

Pharmacology study

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Pupil diameter changes before and after using eye drops

Key secondary outcomes

NRS
AE


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

Low concentration parasympatholytic eye drop once daily for 2 days

Interventions/Control_2

Control drug administered 4 times daily for 2 weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

Informed consent
Pupil diameter difference within 1mm
Rocognize light reflex

Key exclusion criteria

History of serious disease
History of eye surjery or eye trauma
Use of drugs that affect the autonomic nervous system
History of drug allergy
Active eye disease
Insufficient visual acuity
Pregnant

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Shigeru
Middle name
Last name Kinoshita

Organization

ShijoKarasuma-Ganka Komuro Clinic

Division name

ophthalmology

Zip code

604-8152

Address

652 Tearaimizu-cho Nakagyo-ku Kyoto

TEL

075-708-8004

Email

shigeruk@koto.kpu-m.ac.jp


Public contact

Name of contact person

1st name Kojiro
Middle name
Last name Imai

Organization

Kyoto Prefectural University of Medicine

Division name

Department for Medical Innovation and Translational Medical Science

Zip code

602-8566

Address

465 Kajii-cho, kamigyo-ku, Kyoto-shi, Kyoto

TEL

075-251-5308

Homepage URL


Email

kimai@koto.kpu-m.ac.jp


Sponsor or person

Institute

ShijoKarasuma-Ganka Komuro Clinic

Institute

Department

Personal name



Funding Source

Organization

ShijoKarasuma-Ganka Komuro Clinic

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kyoto Expert Ethics Committee

Address

465 Kajiicho, Hirokoji, Kawaramachi, Kamigyoku, Kyoto

Tel

075-221-2621

Email

miki.kyotorinrishinsa@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 06 Month 29 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2024 Year 05 Month 13 Day

Date of IRB

2024 Year 06 Month 10 Day

Anticipated trial start date

2024 Year 06 Month 28 Day

Last follow-up date

2024 Year 09 Month 06 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 06 Month 29 Day

Last modified on

2024 Year 06 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062640